大博医疗（002901）2月5日主力资金净买入41.87万元

Core Viewpoint - The stock of Dabo Medical (002901) has shown a recent increase in price and positive financial performance, indicating potential investment opportunities in the medical device sector. Group 1: Stock Performance - As of February 5, 2026, Dabo Medical closed at 50.14 yuan, up 1.62% with a turnover rate of 0.61% and a trading volume of 17,600 shares, resulting in a transaction value of 88.34 million yuan [1] - On February 5, 2026, the net inflow of main funds was 418,700 yuan, accounting for 0.47% of the total transaction value, while retail investors saw a net inflow of 1.17 million yuan, representing 1.33% of the total [1] Group 2: Financing and Margin Trading - On February 5, 2026, the financing buy amounted to 7.38 million yuan, while financing repayment was 9.08 million yuan, resulting in a net repayment of 1.70 million yuan [1] - The total financing balance on February 5, 2026, was 155 million yuan, with a margin trading balance of 155 million yuan [2] Group 3: Financial Metrics and Industry Comparison - Dabo Medical's total market capitalization is 20.76 billion yuan, with a net profit of 425 million yuan, which is significantly higher than the industry average of 208 million yuan [4] - The company reported a gross margin of 71.23% and a net profit margin of 23.92%, both of which are above the industry averages of 50.55% and 9.59%, respectively [4] - For the first three quarters of 2025, Dabo Medical's main revenue was 1.88 billion yuan, a year-on-year increase of 22.69%, and the net profit attributable to shareholders was 425 million yuan, up 77.03% year-on-year [4]